UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040057
Receipt number R000045637
Scientific Title Impact of moderate-intensity exercise to renal function and exercise capacity of pre-dialysis chronic kidney disease patients.
Date of disclosure of the study information 2020/04/08
Last modified on 2024/04/09 10:59:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of moderate-intensity exercise to renal function and exercise capacity of pre-dialysis chronic kidney disease patients.

Acronym

Impact of moderate-intensity exercise to renal function and exercise capacity of pre-dialysis chronic kidney disease patients.

Scientific Title

Impact of moderate-intensity exercise to renal function and exercise capacity of pre-dialysis chronic kidney disease patients.

Scientific Title:Acronym

Impact of moderate-intensity exercise to renal function and exercise capacity of pre-dialysis chronic kidney disease patients.

Region

Japan


Condition

Condition

pre-dialysis chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine the effect of moderate-intensity exercise to renal function and exercise capacity of pre-dialysis chronic kidney disease patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change rate of eGFR at 12 months

Key secondary outcomes

Change of exercise capacity at 12 months
Muscle mass measured by bioelectrical impedance analysis


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

walking, 30 minites per day, 5 times per weeks

Interventions/Control_2

no intervention

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

eGFR 16-60 ml/min/1.73m2.
The patients who attend a hospital for more than 1 year.

Key exclusion criteria

The patients who need help during walking.
Hypermetabolism.
Acute on chronic kidney disease.
The patients who are suspected heart disease.
Heart failure (NYHA 2-4).
Acute myocardial infarction, congestive heart failure, or stroke during past 1 year.
Angina.
Intermittent claudication.
Chronic obstructive pulmonary disease.
Malignancy on treatment.
Mental disease or dimentia.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Okushima

Organization

Osaka general medical center

Division name

Division of nephrology and hypertension

Zip code

558-8558

Address

3-1-56, Bandaihigashi,Sumiyoshi-ku, Osaka

TEL

06-6692-1201

Email

h.okushima00@gmail.com


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Okushima

Organization

Osaka general medical center

Division name

Division of nephrology and hypertension

Zip code

558-8558

Address

3-1-56, Bandaihigashi,Sumiyoshi-ku, Osaka

TEL

06-6692-1201

Homepage URL


Email

h.okushima00@gmail.com


Sponsor or person

Institute

Osaka general medical center

Institute

Department

Personal name



Funding Source

Organization

no

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka general medical center, clinical research center

Address

3-1-56, Bandaihigashi,Sumiyoshi-ku, Osaka

Tel

06-6692-1201

Email

kenkyusien@gh.opho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪急性期・総合医療センター


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 03 Month 01 Day

Date of IRB

2019 Year 02 Month 06 Day

Anticipated trial start date

2019 Year 03 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Ongoing
participant:13


Management information

Registered date

2020 Year 04 Month 04 Day

Last modified on

2024 Year 04 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045637


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name